Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Zhao, Fujun ^a,b   Chen, Xiaoyi ^a   Meng, Tingting ^b   Hao, Bo ^a   Zhang, Zhihong ^a   Zhang, Guoxin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Jiangyan People's Hospital   (China)

Author keywords

Gastric cancer; Genetic variants; Metastasis; Osteopontin; Polymorphisms

Indexed keywords

GENOMIC DNA; LUCIFERASE; OSTEOPONTIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH CARCINOGENESIS; SURVIVAL RATE;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84867410664     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-477     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Eslick GD, Lim LL-Y, Byles JE, Xia HH-X, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999, 94:2373-2379. 10.1111/j.1572-0241.1999.01360.x, 10483994.
3. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002, 100:249-260. 10.1002/ijc.10466, 12115538.
4. Gonzalez CA. EPIC working group on gastric cancer: vegetable, fruit and cereal consumption and gastric cancer risk. IARC Sci Publ 2002, 156:79-83S.
5. Suerbaum S, Michetti P. Helicobacter pylroi infection. N Engl J Med 2002, 347:1175-1186. 10.1056/NEJMra020542, 12374879.
6. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004, 31:450-464. 10.1053/j.seminoncol.2004.04.021, 15297938.
7. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaquchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacer pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784-789. 10.1056/NEJMoa001999, 11556297.
8. Torre GL, Boccia S, Ricciardi G. Glutathione S-Transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 2005, 217:53-60. 10.1016/j.canlet.2004.08.020, 15596296.
9. Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence. Proc nat Acad Sci(wash) 1986, 83:8819-8823.
10. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006, 16:79-87. 10.1016/j.tcb.2005.12.005, 16406521.
11. Senger DR, Perruzzi CA, Gracey CF, Papadopoulos A, Tenen DG. Secreted phosphoproteins associated with neoplastic transformation: closed homology with plasma proterins cleaved during blood coagulation. Cancer Res 1998, 48:5770-5774.
12. Bellahcene A, Gastronovo V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 1995, 146:95-100. 1870781, 7856741.
13. Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, Chambers AF, Harris JF. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 1997, 3:605-611.
14. Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ, Chi NH, Chen GH, Lin JT. Elevated plasma osteopontin associated with gastric cancer development,invasion, and survival. Gut 2007, 56:782-789. 10.1136/gut.2006.109868, 1954839, 17148500.
15. Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44v interaction enhances survival in gastrointestinal cancer cells. Cancer Res 2007, 67:2089-2097. 10.1158/0008-5472.CAN-06-3625, 17332338.
16. Marciano R, Giacopelli F, Divizia MT, Gattorno M, Felici E, Pistorio A, Martini A, Ravazzolo R, Picco P. A polymorphism variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis. Ann Rheum Dis 2006, 65:662-665. 10.1136/ard.2005.040626, 1798121, 16150788.
17. Gao B, Yasui T, Itoh Y, Li Z, Okada A, Tozawa K, Hayashi Y, Kohri K. Association of osteopontin gene haplotypes with nephrolothiasis. Kidney Int 2007, 72:592-598. 10.1038/sj.ki.5002345, 17519954.
18. Mochida S, Hashimoto M, Matsui A, Naito M, Ihao M, Nagoshi S, Nagano M, Egashira T, Mishiro S, Fuiiwara K. Genetic polymorphisms in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients. Bioc Biop Res Commu 2004, 313:1079-1085.
19. Chang YS, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer 2007, 57:373-380. 10.1016/j.lungcan.2007.04.005, 17513004.
20. Shin HD, Park BL, Cheong HS, Yoon JH, Kim YJ, Lee HS. SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int J Epidemiol 2007, 36:1001-1008. 10.1093/ije/dym093, 17496055.
21. Wang XY, Yang Y, Shi RH, Ho B, Wang HD, Zhang GX. An evaluation of a serologic test with a current infection maker of Helicobacter pylori before and after eradication therapy in Chinses. Helicobacter 2008, 13:49-55. 10.1111/j.1523-5378.2008.00578.x, 18205666.
22. Wai PY, Kuo PC. The role of osteopontin in tumor metastasis. J Surg Res 2004, 121:228-241. 10.1016/j.jss.2004.03.028, 15501463.
23. Pratap J, Lian JB, Javed A, Barnes GL, van Wijnen AJ, Stein JL. Regulatory roles of Runx2 in metastatic tumor and cancer cell interaction with bone. Cancer Metast Rev 2006, 25:589-600.
24. EI-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS. Review: The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Reviews 2006, 17:463-474. 10.1016/j.cytogfr.2006.09.010, 17113338.
25. Song G, Quyang G, Mao Y, Bao S, Hu T. Osteopontin promotes gastric cancer metastasjs by augmenting cell suvival and invasion through Akt-mediated HIF-1 up-regulation and MMP9 activation. J Cell Mol Med 2009, 13(8B):1706-1718. 10.1111/j.1582-4934.2008.00540.x, 19602039.
26. Ue T, Yokozaki H, Kitadai Y, Yamamoto S, Yasui W, Ishikawa T, Tahara E. Co-expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer 1998, 79:127-132. 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V, 9583725.
27. Brown LF, Papadopoulos-Sergiou A, Berse B, Mansean EJ, Tonqnazzi K, Perruzzi CA, Dvorak HF, Senger DR. Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994, 145:610-623. 1890312, 8080043.
28. Hummelshoj T, Ryder LP, Madsen HO, Odum N, Svejgaard. A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Mol Immunol 2006, 43:980-986. 10.1016/j.molimm.2005.05.012, 16009426.
29. Schultz J, Lorenz P, Ibrahim SM, Kundt G, Gross G, Kunz M. The funtional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Mol Carcing 2008, 48:14-23.
30. Iwasaki H, Shinohara Y, Ezura Y, Ishida R, Kodaira M, Kajita M, Nakajima T, Shiba T, Emi M. Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals. J Hum Genet 2001, 46:544-546. 10.1007/s100380170037, 11558904.
31. Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R. Polymorphisms in the osteopontin promoter affect its transcription activity. Physiol Cenomics 2004, 20:87-96.